Ledger.Open graph →
SEC Form D · Amendment · filed April 17, 2014

Annovation BioPharma, Inc

Offering
$11.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jason Campagna · Cambridge, MADirectorAnkit Mahadevia · Cambridge, MADirectorDavid Grayzel · Cambridge, MAExec · DirectorCarl Berke · Cambridge, MAExec · DirectorJean-Francois Formela · Cambridge, MADirectorJohn O'Connor · Tulsa, OKExec · DirectorVictor F. Keen · Tulsa, OKExec · DirectorOliver Kwan · Shanghai, IsraelDirectorRaymond P. Tellini · MIAMI, FLDirectorJeffrey Webb · GRAND CAYMAN, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗